End of Jan would tie in with Secondary Outcome Measure 2
2.Optimal biologic dose
[ Time Frame: Up to 3 months ]
Defined as safe dose that induces an immune response in tumors (increase checkpoint target PD-L1 by at least 5% and/or increase T cell infiltration by at least 10%).
- Forums
- ASX - By Stock
- Ann: Update on Clinical Trial of Oncolytic Virotherapy CHECKvacc
End of Jan would tie in with Secondary Outcome Measure...
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.6¢ |
Change
0.001(0.91%) |
Mkt cap ! $402.5M |
Open | High | Low | Value | Volume |
5.6¢ | 5.6¢ | 5.5¢ | $455.8K | 8.239M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
43 | 1291186 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 3130332 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
45 | 1338458 | 0.055 |
36 | 2855627 | 0.054 |
18 | 1838402 | 0.053 |
19 | 1608613 | 0.052 |
25 | 4038376 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 3106696 | 20 |
0.057 | 2296290 | 13 |
0.058 | 1974606 | 9 |
0.059 | 787163 | 5 |
0.060 | 2167416 | 16 |
Last trade - 12.22pm 25/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |